ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors.Essam Ghazaly, Sarah P. Blagden, Hani Gabra et al.|Journal of Clinical Oncology|2013Cited by 8